Suppression of reperfusion arrhythmias by preconditioning is inhibited by an ATP-sensitive potassium channel blocker, 5-hydroxydecanoate, but not by protein kinase C blockers in the rat

Journal of Cardiovascular Pharmacology

Volumn 32, Issue 5, 1998, Pages 791-797

  Kita, Hiroyuki ^a   Miura, Tetsuji ^a   Tsuchida, Akihito ^a   Hasegawa, Thoru ^a   Shimamoto, Kazuaki ^a  

^a SAPPORO MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Opioid receptor; Rats; Reperfusion arrhythmia

Indexed keywords

CALPHOSTIN C; DECANOIC ACID DERIVATIVE; OPIATE RECEPTOR; POTASSIUM CHANNEL; PROTEIN KINASE C; STAUROSPORINE;

ANIMAL EXPERIMENT; ARTICLE; CHANNEL GATING; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; ENZYME ACTIVATION; HEART ARRHYTHMIA; HEART INFARCTION; HEART MUSCLE REPERFUSION; HEART VENTRICLE FIBRILLATION; HEART VENTRICLE TACHYCARDIA; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

ADENOSINE TRIPHOSPHATE; ANIMALS; ANTI-ARRHYTHMIA AGENTS; ARRHYTHMIA; DECANOIC ACIDS; HEMODYNAMIC PROCESSES; HYDROXY ACIDS; ISCHEMIC PRECONDITIONING; MALE; MYOCARDIAL REPERFUSION INJURY; POTASSIUM CHANNEL BLOCKERS; POTASSIUM CHANNELS; PROTEIN KINASE C; RATS; RATS, SPRAGUE-DAWLEY;

EID: 0031734102     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005344-199811000-00016     Document Type: Article

References (47)

1. Miura T, Iimura O. Infarct size limitation by preconditioning: its phenomenological features and the key role of adenosine. Cardiovasc Res 1993;27:36-42.
2. Shiki K, Hearse DJ. Preconditioning of ischemic myocardium: reperfusion-induced arrhythmias. Am J Physiol 1987;253:H1470-6.
3. Miura T, Ishimoto R, Sakamoto J, et al. Suppression of reperfusion arrhythmia by ischemic preconditioning in the rat: is it mediated by the adenosine receptor, prostaglandin, or bradykinin receptor? Basic Res Cardiol 1995;90:240-6.
4. Goto M, Liu Y, Yang XM, Ardell JL, Cohen MJ, Downey MJ. Role of bradykinin in protection of ischemic preconditioning in rabbit hearts. Circ Res 1995;77:611-21.
5. Schultz JJ, Rose E, Yao Z, Gross GJ. Evidence for involvement of opioid receptors in ischemic preconditioning in rat hearts. Am J Physiol 1995;268:H2157-61.
6. Schultz JJ, Hsu AK, Gross GJ. Morphine mimics the cardioprotective effect of ischemic preconditioning via a glibenclamide-sensitive mechanism in the rat heart. Circ Res 1996;78:1100-4.
7. Cohen MV, Liu Y, Downey JM. Activation of protein kinase C is critical to the protection of preconditioning. In: Wainwright CL, Parratt JR, eds. Myocardial preconditioning. Georgetown: R.G. Landes, 1996:185-206.
8. Gross GJ, Mei DA, Schultz JJ, Mizumura T. Criteria for a mediator or effector of myocardial preconditioning: do KATP channels meet the requirements? Basic Res Cardiol 1996;91:31-4.
9. 2 receptors. Br J Pharmacol 1994;113:1167-72.
10. 2+ release from an intracellular pool in myocytes and neurons. Circ Res 1992;70:66-81.
11. Lou LG, Pei G. Modulation of protein kinase C and cAMP-dependent protein kinase by delta-opioid. Biochem Biophys Res Commun 1997;236:626-9.
12. + currents by protein kinase C and adenosine: implications for ischemic preconditioning. Circ Res 1996;78:443-54.
13. + channels: a possible mechanistic link to ischemic preconditioning. Circ Res 1996;79:399-406.
14. Wilde AAM, Janse MJ. Electrophysiological effects of ATP sensitive potassium channel modulation: implications for arrhythmogenesis. Cardiovasc Res 1994;28:16-24.
15. Wit AL, Janse MJ. Basic mechanisms of arrhythmias. In: The ventricular arrhythmias of ischemia and infarction: electrophysiological mechanisms. New York: Futura Publishing, 1993:31-69.
16. Bril A, Laville M-P, Gout B. Effects of glibenclamide on ventricular arrhythmias and cardiac function in ischaemia and reperfusion in isolated rat heart. Cardiovasc Res 1992;26:1069-76.
17. Tosaki A, Szerdahelyi P, Engelman RM, Das DK. Potassium channel openers and blockers: do they possess proarrhythmic or antiarrhythmic activity in ischemic and reperfused rat hearts? J Pharmacol Exp Ther 1993;267:1355-62.
18. Ferdinandy P, Szilvassy Z, Droy-Lefaix MT, Terrade T, Koltai M. KATP channel modulation in working rat hearts with coronary occlusion: effects of cromakalim, cicletanine, and glibenclamide. Cardiovasc Res 1995;30:781-7.
19. Baczko I, Lepran I, Papp JG. KATP channel modulators increase survival rate during coronary occlusion-reperfusion in anaesthetized rats. Eur J Pharmacol 1997;324:77-83.
20. + exchange in cardiac myocytes. Am J Physiol 1992;263:C1096-102.
21. 2+ in cardiac myocytes. Am J Physiol 1991;261:H1671-67.
22. 2+ overload in reperfused ischemic myocardium. Annu Rev Physiol 1990;52:543-59.
23. Walker MJA, Curtis MJ, Hearse DJ, et al. The Lambeth Conventions: guidelines for the study of arrhythmia in ischemia, infarction, and reperfusion. Cardiovasc Res 1988;2:447-55.
24. Ytrehus K, Liu Y, Downey JM. Preconditioning protects ischemic rabbit heart by protein kinase C activation. Am J Physiol 1994;266:H1145-52.
25. Li Y, Kloner RA. Does protein kinase C play a role in ischemic preconditioning in rat hearts? Am J Physiol 1995;268:H426-31.
26. Curtis MJ, Hearse DJ. Ischemia-induced and reperfusion-induced arrhythmias differ in their sensitivity to potassium: implications for mechanisms of initiation and maintenance of ventricular fibrillation. J Mol Cell Cardiol 1989;21:21-40.
27. Manning AS, Hearse DJ. Reperfusion-induced arrhythmias: mechanisms and prevention. J Mol Cell Cardiol 1984;16:497-518.
28. + channel by 5-hydroxydecanoate in guinea pig ventricular myocytes. J Pharmacol Exp Ther 1991;260:702-8.
29. McCullogh JR, Normandin DE, Conder ML, Sleph PG, Dzwonczyk S, Grover GJ. Specific block of the anti-ischemic actions of cromakalim by sodium 5-hydroxydecanoate. Circ Res 1991;69: 949-58.
30. Lu H, Remeysen P, Clerck FD. The protection by ischemic preconditioning against myocardial ischemia- and reperfusion-induced arrhythmias is not mediated by ATP-sensitive potassium channels in rats. Coron Artery Dis 1993;4:649-57.
31. Baines CP, Goto M, Downey JM. Oxygen radicals released during ischemic preconditioning contribute to cardioprotection in the rabbit myocardium. J Mol Cell Cardiol 1997;29:207-16.
32. Miura T, Miura T, Kawamura S, et al. Effect of protein kinase C inhibitors on cardioprotection by ischemic preconditioning depends on the number of preconditioning episodes. Cardiovasc Res 1998;37: 700-9.
33. Rozanski GJ, Witt RC. Early afterdepolarizations and triggered activity in rabbit cardiac Purkinje fibers recovering from ischemic-like conditions: role of acidosis. Circulation 1991;83: 1352-60.
34. + channels protect the myocardium against ischemia/reperfusion damage. Circ Res 1991;69:571-81.
35. Lathrop DA, Nanasi PP, Varro A. In vitro cardiac models of dog Purkinje fibre triggered and spontaneous electrical activity: effects of nicorandil. Br J Pharmacol 1990;99:119-23.
36. + current activated by pinacidil. Circ Res 1991;68:1127-37.
37. Fish FA, Prakash C, Roden DM. Suppression of repolarization-related arrhythmias in vitro and in vivo by low-dose potassium channel activators. Circulation 1990;82:1362-9.
38. Carlsson L, Abrahamsson C, Drews L, Duker G. Antiarrhythmic effects of potassium channel openers in rhythm abnormalities related to delayed repolarization. Circulation 1992;85:1491-500.
39. + channel? Circ Res 1995;77:1030-5.
40. Van Winkle DM, Kuzume K, Dote K, Wolff RA. Infarct limitation by protein kinase C (PKC) is attenuated by blockade of ATP-sensitive potassium (KATP) channels [Abstract]. J Mol Cell Cardiol 1995;27:A142.
41. Ovize M, Aupetit JF, Rioufol G, et al. Preconditioning reduces infarct size but accelerates time to ventricular fibrillation in ischemic pig heart. Am J Physiol 1995;269:H72-9.
42. Sitsapesan R, Parratt JR. The effect of drugs interacting with opioid receptors on the early ventricular arrhythmias arising from myocardial ischemia. Br J Pharmacol 1989;97:795-800.
43. Wong TM, Lee AY-S, Tai KK. Effects of drugs interacting with opioid receptors during normal perfusion or ischemia and reperfusion in the isolated rat heart. J Mol Cell Cardiol 1990;22:1167-75.
44. Darlison MG, Greten FR, Harvey RJ, et al. Opioid receptors from a lower vertebrate (Catostomus commersoni): sequence, pharmacology, coupling to a G-protein-gated inward-rectifying potassium channel (GIRK1), and evolution. Proc Natl Acad Sci U S A 1997;94:8214-9.
45. Miyoshi S, Miyazaki T, Moritani K, Ogawa S. Different responses of epicardium and endocardium to KATP channel modulators during regional ischemia. Am J Physiol 1996;271:H140-7.
46. Graf BM, Vicenzi MN, Martin-E, Bosnjak-ZJ, Stowe-DF. Ketamine has stereospecific effects in the isolated perfused guinea pig heart. Anesthesiology 1995;82:1426-37.
47. Maxwell MP, Hearse DJ, Yellon DM. Species variation in the coronary collateral circulation during regional myocardial ischaemia: a critical determinant of the rate of evolution and extent of myocardial infarction. Cardiovasc Res 1987;21:737-46.